Dizal (Jiangsu) Pharmaceutical Co., Ltd. (SHA:688192)
China · Delayed Price · Currency is CNY 46.94
+0.18 (0.38%)
At close: Jul 13, 2026
SHA:688192 Market Cap
SHA:688192 has a market cap or net worth of 21.83 billion as of July 13, 2026. Its market cap has decreased by -26.03% in one year.
Market Cap
21.83B
Enterprise Value
21.35B
Revenue
894.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
46.94
Market Cap Chart
Since December 10, 2021, SHA:688192's market cap has increased from 16.44B to 21.83B, an increase of 32.82%. That is a compound annual growth rate of 6.38%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 13, 2026 | 21.83B | -17.80% |
| Dec 31, 2025 | 26.56B | 54.11% |
| Dec 31, 2024 | 17.24B | -11.74% |
| Dec 29, 2023 | 19.53B | 21.84% |
| Dec 30, 2022 | 16.03B | 7.16% |
| Dec 31, 2021 | 14.96B | -9.01% |
| Dec 10, 2021 | 16.44B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zhejiang Huahai Pharmaceutical | 25.10B |
| Tianjin Pharmaceutical Da Ren Tang Group Corporation | 24.96B |
| Livzon Pharmaceutical Group | 24.59B |
| Hybio Pharmaceutical | 22.47B |
| Hubei Jumpcan Pharmaceutical | 22.08B |
| Tasly Pharmaceutical Group | 21.03B |
| Walvax Biotechnology | 21.02B |
| Jilin Aodong Pharmaceutical Group | 20.68B |